Concourse Financial Group Securities’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
ACA
Concourse Financial Group Securities's UTHR Position: Q3 2024 in Review
Concourse Financial Group Securities sold out of United Therapeutics (UTHR) in Q3 2024, closing a stake of 5 shares — an estimated $1.69K sold.
Concourse Financial Group Securities first reported a position in UTHR in Q3 2018 and held it in 19 quarters. The position peaked at $34K in Q2 2022. 625 funds tracked by Wall St. Rank hold UTHR as of Q3 2024.
- Concourse Financial Group Securities reported no remaining United Therapeutics position as of Q3 2024 after selling out during the quarter.
- Concourse Financial Group Securities sold 5 United Therapeutics shares in Q3 2024, an estimated $1.69K.
- Concourse Financial Group Securities first reported a position in United Therapeutics in Q3 2018 and held it in 19 quarters.
- Concourse Financial Group Securities's United Therapeutics position peaked at $34K in Q2 2022.
- 625 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2024.
Based on Concourse Financial Group Securities's 13F filing for Q3 2024, filed 10 Oct 2024.